medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2026, Number 1

<< Back Next >>

Rev Latin Infect Pediatr 2026; 39 (1)

Complicated malaria with suspected Blackwater fever: presentation of two cases

Guillén MS, Sánchez MB, Alcántara RC, Pons EM, Fumadó PV, García LHM

Language: Spanish
References: 15
Page: 5-9
PDF size: 800.32 Kb.


ABSTRACT

Blackwater fever is a serious complication of malaria characterized by massive intravascular haemolysis, which leads to haemoglobinuria, anaemia, and, in some cases, acute kidney injury. Its pathophysiology is not well understood. We present two cases of blackwater fever in two children with Plasmodium falciparum malaria treated with artemisinin-based therapies. We emphasize the importance of diagnosing blackwater fever as a complication in children with malaria, making the differential diagnosis with other causes of haemoglobinuria.


REFERENCES

  1. Rodari P, Tamarozzi F, Fittipaldo VA, Buonfrate D, Gobbi F. Physiopathology and clinical management of blackwater fever: a scoping review. Clin Microbiol Infect. 2024; 30 (1): 59-65.

  2. Bodi JM, Nsibu CN, Longenge RL et al. Blackwater fever in Congolese children: a report of clinical, laboratory features and risk factors. Malar J. 2013; 12: 205.

  3. Olupot-Olupot P, Engoru C, Uyoga S et al. High frequency of Blackwater Fever among children presenting to hospital with severe febrile illnesses in Eastern Uganda. Clin Infect Dis. 2017; 64 (7): 939-946.

  4. Dondorp A, Nosten F, Stepniewska K, Day N, White N. South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005; 366: 717-725.

  5. Dondorp AM, Fanello CI, Hendriksen ICE et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010; 376: 1647-1657.

  6. Namazzi R, Mellencamp KA, Opoka RO et al. Circulating immune complexes and glucose-6-phosphate dehydrogenase deficiency predict recurrent blackwater fever in ugandan children with severe malaria. J Infect Dis. 2025; 232 (2): 285-297.

  7. Tombe M. Images in clinical medicine. Hemoglobinuria with malaria. N Engl J Med. 2008; 358 (17): 1837.

  8. Jaita S, Madsalae K, Charoensakulchai S et al. Post-artesunate delayed hemolysis: a review of current evidence. Trop Med Infect Dis. 2023; 8 (1): 49.

  9. George CR. Blackwater fever: the rise and fall of an exotic disease. J Nephrol. 2009; 22 (Suppl 14): 120-128.

  10. Opoka RO, Waiswa A, Harriet N et al. Blackwater fever in ugandan children with severe anemia is associated with poor postdischarge outcomes: a prospective cohort study. Clin Infect Dis. 2020; 70 (11): 2247-2254.

  11. Conroy AL, Hawkes MT, Leligdowicz A et al. Blackwater fever and acute kidney injury in children hospitalized with an acute febrile illness: pathophysiology and prognostic significance. BMC Med. 2022; 20 (1): 221.

  12. Singh I, Singh I. Treatment of blackwater fever. Ind Med Gaz. 1944; 79 (6): 256-258.

  13. Trowell HC, Vaizey JM. Treatment of blackwater fever with prednisone. Lancet. 1956; 271 (6956): 1281-1282.

  14. Odiit A, Lubogo P, Ochora M, Ebiju I, Opito R. Effect of corticosteroids on haemoglobinuria resolution among children with blackwater fever at Soroti regional referral hospital, Uganda: a retrospective cohort study. Malar J. 2025; 24 (1): 366.

  15. WHO guidelines for malaria, 13 August 2025. Geneva: World Health Organization; 2025.




2020     |     www.medigraphic.com